MRTX - Mirati Therapeutics GAAP EPS of -$3.18 beats by $0.32 revenue of $5.36M beats by $4.98M August, 03 2022 04:22 PM Mirati Therapeutics Inc. Mirati Therapeutics press release ( NASDAQ: MRTX ): Q2 GAAP EPS of -$3.18 beats by $0.32 . Revenue of $5.36M beats by $4.98M . For further details see: Mirati Therapeutics GAAP EPS of -$3.18 beats by $0.32, revenue of $5.36M beats by $4.98M